The Cholesterol-Virus Axis: From Pathogenic Mechanisms to Host-Directed Therapies
Cholesterol plays a vital role in cellular membranes and serves as a key signaling molecule, positioning itself at the intersection of viral infection and host immunity. Viruses from various families have developed advanced mechanisms to exploit host cholesterol metabolism, manipulating its synthesis, trafficking, and distribution to aid in their entry, replication, and egress. This review consolidates current insights into how viruses, such as coronaviruses, flaviviruses, and hepatitis viruses, commandeer cholesterol-rich membrane domains and biosynthetic pathways, including the SREBP cascade, to create environments conducive to their life cycles. In response, hosts have evolved countermeasures, utilizing interferon-stimulated genes like IFITM3 and CH25H, which produces the antiviral oxysterol 25-hydroxycholesterol, to disrupt cholesterol homeostasis and limit viral spread. We examine the clinical implications of this metabolic struggle, including dyslipidemia, steatosis, and insulin resistance linked to chronic infections like HCV and HIV. Finally, we assess the therapeutic potential of targeting the virus-cholesterol axis, considering the use of repurposed lipid-lowering drugs (e.g., statins, PCSK9 inhibitors) and novel host-directed therapies as broad-spectrum antiviral strategies. This review underscores cholesterol's dual role as both a crucial resource for viruses and a powerful component of the host's antiviral defense.
Authors
- Yuhan Zhao (ORCID: https://orcid.org/0000-0002-4729-1824)
- Jing Sha
- Wenyu Qiu
- Haixu Xu
Publication Details
- Journal
- Preprints.org
- Published
- 2026-11-17
- DOI
- https://doi.org/10.20944/preprints202611.1683.v1
- Primary Topic
- Cholesterol and Lipid Metabolism
- Type
- preprint